Skip to content

BIO FRONTIER

  • Home
  • Artificial intelligence
  • Biotechnology
  • Genetics
  • Medical Technology
    • Home
    • Uncategorized
    • AbbVie sees negative Q4 EPS impact from IPR&D expenses

AbbVie sees negative Q4 EPS impact from IPR&D expenses

Jan 8, 2026

Post navigation

Bionova Scientific and Syenex Forge Strategic Alliance to Expand Access to High-Quality Plasmid DNA for Advanced Therapies
The Board of Medicine Launches Membership Program Expanding Access to Emerging Medical Knowledge
  • PR Newswire
  • GlobeNewswire
  • Contact
  • Privacy Policy

BIO FRONTIER

Header Toggle Sidebar

This is an example widget to show how the Header Toggle Sidebar looks by default. You can add custom widgets from the widgets in the admin.